Total lymphoid irradiation in clinical kidney transplantation

J. A. Myburgh,A. M. Meyers,J. R. Botha,P. D. Thomson,J. A. Smit,R. Lakier

DOI: https://doi.org/10.1111/j.1399-0012.1987.tb00692.x

1987-04-01

Clinical Transplantation

Abstract:Total lymphoid irradiation was administered preoperatively to 37 patients receiving 38 kidney allografts. A basic dose of 800 cGy, was administered in twice weekly fractions of 60 to 100 cGy to a wide field. Follow‐up has ranged from I month to 5 years 8 months. Overall graft survival in 35 immunologically evaluable transplants (3 technical exclusions) is 89%. Actual 1‐yr graft survival for 17 patients at risk for this period is 88%, and 93% for 15 first cadaver grafts. Patient survival is 97%. All patients received low dose immunosuppressive drugs after transplantation, azathioprine and prednisone in 2, prednisone alone in 2 and cyclosporine (starting dose 6 mg/kg/day) and prednisone (20 mg/d) in 31. In 1 patient azathioprine and prednisone were withdrawn 3 yr after transplantation and graft function remains normal 2 yr 8 months later. Two further patients receive only small doses of prednisone (4 and 5 mg/d) more than 2 yr after transplantation, after cyclosporine had been withdrawn approximately 2 months postoperatively. Mean serum creatine is 123 ± 45 μlmol/l, and all but 2 patients have values <200 μmol/l. Over one half of the patients have never experienced any rejection episodes. When these have occurred they have been readily reversible except in 3 instances. Infective complications have been uncommon. Wide field, low dose total lymphoid irradiation in this center has resulted in better graft and patient survival, and better graft function than in patients not receiving it. It has permitted the use of substantially lower doses of immunosuppressive drugs, and infective complications have been rare. Transplantation tolerance appears to have resulted in 1 patient thus far, and may also have developed in 2 further patients.

surgery,transplantation